Finance

Lists
Why is NSRX down 3,49%?
Dive Deeper
NSRX:NYSEAMERICAN
Nasus Pharma Ltd
3,32 US$
-3,49%
(-0,12) 1D
12 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NSRX...
Open
3,33 US$
High
3,44 US$
Low
3,24 US$
Mkt. cap
38,89 მლნ.
Avg. vol.
18,16 ათ.
Volume
30,88 ათ.
52-wk high
9,50 US$
52-wk low
1,98 US$
EPS
-1,13 US$
Shares outstanding
11,71 მლნ.
No. of employees
7
Open
3,33 US$
High
3,44 US$
Low
3,24 US$
Mkt. cap
38,89 მლნ.
Avg. vol.
18,16 ათ.
Volume
30,88 ათ.
52-wk high
9,50 US$
52-wk low
1,98 US$
EPS
-1,13 US$
Shares outstanding
11,71 მლნ.
No. of employees
7
News stories
From web sources and news partners
About Nasus Pharma Ltd
CEO-
Employees7
Founded2019
Headquarters-
SectorPharmaceutical industry
Websitenasuspharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
1,29 მლნ.
1,29 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
1,73 მლნ.
1,73 მლნ.
Operating expense
-
-
3,02 მლნ.
3,02 მლნ.
Total operating expenses
-
-
3,02 მლნ.
3,02 მლნ.
Operating income
-
-
-3,02 მლნ.
-3,02 მლნ.
Other non operating income
-
-
-17,50 ათ.
-17,50 ათ.
EBT including unusual items
-
-
-2,97 მლნ.
-2,97 მლნ.
EBT excluding unusual items
-
-
-2,97 მლნ.
-2,97 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-2,97 მლნ.
-2,97 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
64,00 ათ.
64,00 ათ.
Interest expense
-
-
-
-
Net interest expenses
-
-
64,00 ათ.
64,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები